The biochemical basis of neurodegenerative disease: The role of immunoexcitoxicity and ways to possibly attenuate it
- PMID: 37151454
- PMCID: PMC10159298
- DOI: 10.25259/SNI_250_2023
The biochemical basis of neurodegenerative disease: The role of immunoexcitoxicity and ways to possibly attenuate it
Abstract
There is growing evidence that inflammation secondary to immune activation is intimately connected to excitotoxicity. We now know that most peripheral tissues contain fully operational glutamate receptors. While most of the available research deals with excitotoxicity in central nervous system (CNS) tissues, this is no longer true. Even plant has been found to contain glutamate receptors. Most of the immune cells, including mask cells, contain glutamate receptors. The receptors are altered by inflammation, both chemokine and cytokines. A host of new diseases have been found that are caused by immunity to certain glutamate receptors, as we see with Rasmussen's encephalitis. In this paper, I try to explain this connection and possible ways to reduce or even stop the reaction.
Keywords: Autoimmunity; Flavonoids; Immunoexcitotoxicity; Neurodegeneration.
Copyright: © 2023 Surgical Neurology International.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders.Surg Neurol Int. 2025 Jan 31;16:26. doi: 10.25259/SNI_1114_2024. eCollection 2025. Surg Neurol Int. 2025. PMID: 39926461 Free PMC article.
-
Additive aluminum as a cause of induced immunoexcitoxicity resulting in neurodevelopmental and neurodegenerative disorders: A biochemical, pathophysiological, and pharmacological analysis.Surg Neurol Int. 2024 May 24;15:171. doi: 10.25259/SNI_296_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 38840623 Free PMC article.
-
Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua.Epilepsia. 2005;46 Suppl 5:152-8. doi: 10.1111/j.1528-1167.2005.01024.x. Epilepsia. 2005. PMID: 15987271
-
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
-
Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum.Surg Neurol Int. 2018 Apr 9;9:74. doi: 10.4103/sni.sni_407_17. eCollection 2018. Surg Neurol Int. 2018. PMID: 29721353 Free PMC article. Review.
References
-
- Ana RS, Cristina GR, Justo GY. Vitamin B6 deficiency in patients with Parkinson’s disease treated with Levodopa/ carbidopa. Clin Neuropharm. 2020;43:151–7. - PubMed
-
- Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2008;58:1130–5. - PubMed
-
- Attia AM, Badar BA, Alibalaihad R, Alharshan R, Almukhaitah AA. Crezutzfelt-Jakob disease after the second dosage of the novel Pfizer-biotech messenger ribonucleic acid (Mrna) COVID-19 vaccination: A case report. HIV Nurs. 2023;1:743–7.
-
- Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A. The multifaceted therapeutic potential of benfotiamine. Pharmacol Res. 2010;61:482–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources